Nanjing Vazyme Biotech Co., Ltd.

Nanjing Vazyme Biotech Co., Ltd.verified

688105.SS

Price:

$21.73

Market Cap:

$8.64B

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diag...[Read more]

Industry

Biotechnology

IPO Date

2021-11-15

Stock Exchange

SHH

Ticker

688105.SS

The PE Ratio as of December 2025 (TTM) for Nanjing Vazyme Biotech Co., Ltd. (688105.SS) is -271.62

According to Nanjing Vazyme Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -271.62. This represents a change of -129.26% compared to the average of 928.23 of the last 4 quarters.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Historical PE Ratio (quarterly & annually)

How has 688105.SS PE Ratio performed in the past?

The mean historical PE Ratio of Nanjing Vazyme Biotech Co., Ltd. over the last ten years is 4.80K. The current -271.62 PE Ratio has changed -666.43% with respect to the historical average. Over the past ten years (40 quarters), 688105.SS's PE Ratio was at its highest in in the June 2025 quarter at 1.85K. The PE Ratio was at its lowest in in the June 2023 quarter at -100.07.

Quarterly (TTM)
Annual

Average

4.80K

Median

52.03

Minimum

-486.21

Maximum

29.23K

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nanjing Vazyme Biotech Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 250.87%

Maximum Annual PE Ratio = 29.23K

Minimum Annual Increase = -589.23%

Minimum Annual PE Ratio = -486.21

Quarterly (TTM)
Annual
YearPE RatioChange
2024-486.21177.83%
2023-175.00-589.23%
202235.77-42.78%
202162.5150.46%
202041.55-96.86%
20191.32K-95.47%
201829.23K250.87%

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Average PE Ratio

How has 688105.SS PE Ratio performed in the past?

The current PE Ratio of Nanjing Vazyme Biotech Co., Ltd. (688105.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-208.48

5-year avg

-104.28

10-year avg

4.80K

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) PE Ratio vs. Peers

How is 688105.SS’s PE Ratio compared to its peers?

Nanjing Vazyme Biotech Co., Ltd.’s PE Ratio is less than Daan Gene Co., Ltd. (-15.73), less than Youcare Pharmaceutical Group Co., Ltd. (-46.12), less than Chengzhi Shareholding Co., Ltd. (79.60), less than Chengdu Olymvax Biopharmaceuticals Inc. (169.71), less than Anhui Huaheng Biotechnology Co., Ltd. (46.13), less than Aurisco Pharmaceutical Co.,Ltd. (21.05), less than Guilin Sanjin Pharmaceutical Co., Ltd. (16.81), less than Chengdu Kanghua Biological Products Co., Ltd. (56.42), less than Zhejiang Ausun Pharmaceutical Co., Ltd. (43.33), less than Hunan Jiudian Pharmaceutical Co., Ltd. (17.05),

Build a custom stock screener for Nanjing Vazyme Biotech Co., Ltd. (688105.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing Vazyme Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nanjing Vazyme Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Nanjing Vazyme Biotech Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Nanjing Vazyme Biotech Co., Ltd. (688105.SS)?

What is the highest PE Ratio for Nanjing Vazyme Biotech Co., Ltd. (688105.SS)?

What is the 3-year average PE Ratio for Nanjing Vazyme Biotech Co., Ltd. (688105.SS)?

What is the 5-year average PE Ratio for Nanjing Vazyme Biotech Co., Ltd. (688105.SS)?

How does the current PE Ratio for Nanjing Vazyme Biotech Co., Ltd. (688105.SS) compare to its historical average?